ctDNA Monitoring to Predict the Efficacy of TNT for Rectal Cancer

NCT06589388 · clinicaltrials.gov ↗

RECRUITING

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Rectal Cancer
Rectal Cancer Stage II
Rectal Cancer Stage III

Sponsor

Gene Solutions